ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,571Medicare Part D Prescriptions Filled, Including Refills

Rank: 362 out of 1206

$382K Total Retail Price of All Prescriptions

Rank: 328 out of 1206

309 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 309 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 309 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 6,038 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
OMEPRAZOLE 439 346 1 3
LEVOTHYROXINE SODIUM 351 319 2 2
SIMVASTATIN 285 245 3 1
LISINOPRIL 250 199 4 4
FUROSEMIDE 217 182 5 5
METOPROLOL TARTRATE 166 150 6 9
WARFARIN SODIUM 161 146 7 8
ALENDRONATE SODIUM 160 131 8 19
CRESTOR 140 112 9 30
HYDROCODONE-ACETAMINOPHEN 134 75 S3 10 7
CITALOPRAM HBR 122 116 11 16
AMLODIPINE BESYLATE 117 101 12 6
METOPROLOL SUCCINATE 113 106 13 15
MELOXICAM 98 84 14 35
ATORVASTATIN CALCIUM 94 82 15 13
NABUMETONE 92 44 16 91
LOSARTAN POTASSIUM 92 88 16 20
DIOVAN 88 88 18 57
METFORMIN HCL 88 55 18 10
POTASSIUM CHLORIDE 86 60 20 12
MIRTAZAPINE 83 62 21 50
HYDROCHLOROTHIAZIDE 82 53 22 11
FENOFIBRATE 79 48 23 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 57 24 27
FENTANYL 76 76 S2 25 51
BENAZEPRIL HCL 76 73 25 39
CYMBALTA 75 45 27 63
TRAMADOL HCL 75 46 27 17
NEXIUM 75 42 27 47
CELEBREX 70 66 30 84
PRAVASTATIN SODIUM 70 64 30 21
ZOLPIDEM TARTRATE 67 37 32 25
VESICARE 63 39 33 148
SERTRALINE HCL 63 63 33 22
METFORMIN HCL ER 60 57 35 58
LEVOFLOXACIN 55 46 36 78
POLYETHYLENE GLYCOL 3350 53 52 37 31
ALLOPURINOL 53 41 37 24
PREDNISONE 51 46 39 28
OXYBUTYNIN CHLORIDE 50 38 40 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.